Offer - Urjas Oil for just ₹ 1
Olmin 20 H Tablet is a prescription drug, available for use as Tablet. Olmin 20 H Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Olmin 20 H Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Olmin 20 H Tablet also has some side effects, the most common being Upper respiratory tract infection. Apart from the aforementioned side effects, Olmin 20 H Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Olmin 20 H Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Olmin 20 H Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Olmin 20 H Tablet's effects on the liver, heart and kidney are discussed below in the Olmin 20 H Tablet related warnings section.
Olmin 20 H Tablet is contraindicated in people with pre-existing medical conditions like Asthma, Allergy, Kidney Disease as it can result in adverse effects. The section on Olmin 20 H Tablet contraindications lists all such conditions.
Besides this, Olmin 20 H Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Olmin 20 H Tablet is not safe while driving, and is is not addictive in nature.
Olmin 20 H Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmin 20 H Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Olmin H. If you are pregnant, do not take Olmin H without a doctor's advice.
Is the use of Olmin 20 H Tablet safe during breastfeeding?
Side effects of Olmin H for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Olmin 20 H Tablet on the Kidneys?
Olmin H rarely affects the kidneys.
What is the effect of Olmin 20 H Tablet on the Liver?
Side effects of Olmin H rarely affect the liver.
What is the effect of Olmin 20 H Tablet on the Heart?
Very few cases of side effects of Olmin H on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Olmin 20 H Tablet unless your doctor advises you to do so -
Is this Olmin 20 H Tablet habit forming or addictive?
No, you will not get addicted to Olmin 20 H Tablet.
Interaction between Food and Olmin 20 H Tablet
When consumed with certain foods, Olmin 20 H Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Olmin 20 H Tablet
Consumption of alcohol and Olmin 20 H Tablet together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173